US20030191279A1
(en)
|
1999-08-27 |
2003-10-09 |
Goldstein Steven Wayne |
Urea derivatives useful as anticancer agents
|
US6576632B1
(en)
|
1999-08-27 |
2003-06-10 |
Pfizer Inc |
Biaryl compounds useful as anticancer agents
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
CA2385592C
(en)
|
1999-09-17 |
2011-01-11 |
Bing-Yan Zhu |
Benzamides and related inhibitors of factor xa
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
CA2387892A1
(en)
|
1999-10-18 |
2001-04-26 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
WO2001064642A2
(en)
|
2000-02-29 |
2001-09-07 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
JP2003530384A
(ja)
|
2000-04-06 |
2003-10-14 |
メルク フロスト カナダ アンド カンパニー |
カテプシンシステインプロテアーゼ阻害薬
|
CN1479722A
(zh)
|
2000-12-06 |
2004-03-03 |
���ĵ�˹ҩ��¹�����˾ |
作为因子Xa抑制剂的胍和脒衍生物
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
JP2005507875A
(ja)
|
2001-08-31 |
2005-03-24 |
ユニバーシティ オブ コネチカット |
カンナビノイド受容体に作用する新規なピラゾール類似体
|
PL215132B1
(pl)
|
2002-06-27 |
2013-10-31 |
Novo Nordisk As |
Pochodna arylokarbonylowa jako srodek terapeutyczny, jej zastosowanie i kompozycja farmaceutyczna ja zawierajaca
|
CA2495179A1
(en)
|
2002-08-09 |
2004-02-19 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
US20040132726A1
(en)
|
2002-08-09 |
2004-07-08 |
Astrazeneca Ab And Nps Pharmaceuticals, Inc. |
New compounds
|
WO2004080966A1
(ja)
|
2003-03-14 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
MXPA05012281A
(es)
|
2003-05-14 |
2006-05-19 |
Torreypines Therapeutics Inc |
Compuestos y uso de los mismos en la modulacion beta amiloide.
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
WO2005019200A2
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
TWI316955B
(en)
|
2003-11-19 |
2009-11-11 |
Chisso Corp |
Photo-polymerization liquid composition,polymer or polymer co mposition and optical compensation device thereof
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
BRPI0507501A
(pt)
|
2004-02-18 |
2007-06-26 |
Astrazeneca Ab |
composto, composição farmacêutica, uso do composto, método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
WO2005087235A1
(en)
|
2004-03-09 |
2005-09-22 |
National Health Research Institutes |
Pyrrolidine compounds
|
DE112005001070T5
(de)
|
2004-05-21 |
2007-04-12 |
Merck Patent Gmbh |
Flüssigkristallverbindungen, Flüssigkristallmedium und Flüssigkristallanzeige
|
EP1758571A1
(en)
|
2004-05-29 |
2007-03-07 |
7TM Pharma A/S |
Crth2 receptor ligands for therapeutic use
|
US8022063B2
(en)
|
2004-05-29 |
2011-09-20 |
7Tm Pharma A/S |
CRTH2 receptor ligands for medicinal uses
|
WO2006015279A1
(en)
|
2004-07-28 |
2006-02-09 |
Neurogen Corporation |
Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders
|
JP5275628B2
(ja)
|
2004-08-25 |
2013-08-28 |
ターゲジェン インコーポレーティッド |
複素環式化合物および使用方法
|
JP4846724B2
(ja)
|
2004-09-06 |
2011-12-28 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
重合性液晶材料
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
WO2006063113A2
(en)
|
2004-12-07 |
2006-06-15 |
Portola Pharmaceuticals, Inc. |
Ureas as factor xa inhibitors
|
CA2593156C
(en)
|
2005-01-10 |
2015-05-05 |
Exelixis, Inc. |
Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
|
CA2594488C
(en)
|
2005-01-10 |
2015-04-28 |
University Of Connecticut |
Novel heteropyrrole analogs acting on cannabinoid receptors
|
GB2424881B
(en)
|
2005-04-07 |
2010-11-24 |
Merck Patent Gmbh |
Halophenyl derivatives of bisalkylfluorene
|
EP2527337A1
(en)
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
EP1891038B1
(en)
|
2005-05-13 |
2008-10-29 |
Eli Lilly And Company |
Substituted n-arylpyrrolidines as selective androgen receptor modulators
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
WO2007024744A2
(en)
|
2005-08-21 |
2007-03-01 |
Exelixis, Inc. |
Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
US20080004273A1
(en)
|
2006-05-30 |
2008-01-03 |
Stephane Raeppel |
Inhibitors of protein tyrosine kinase activity
|
EP2044017A2
(en)
|
2006-06-09 |
2009-04-08 |
Icos Corporation |
Substituted phenyl acetic acids as dp-2 antagonists
|
TW200815437A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
TW200815438A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
WO2008028553A1
(en)
|
2006-09-02 |
2008-03-13 |
Merck Patent Gmbh |
Particle beam process for the alignment of reactive mesogens
|
CA2913963A1
(en)
|
2006-12-08 |
2008-06-19 |
Millenium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
AR064348A1
(es)
|
2006-12-15 |
2009-04-01 |
Bayer Schering Pharma Ag |
3-h-pirazolopiridinas y sales de estas, composiciones farmaceuticas que las comprenden, metodos para prepararlas y sus usos
|
EP2125781A2
(en)
|
2006-12-20 |
2009-12-02 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
MX2009012285A
(es)
|
2007-05-22 |
2009-12-15 |
Via Pharmaceuticals Inc |
Inhibidores de diacilglicerol aciltransferasa.
|
KR101077417B1
(ko)
|
2007-06-12 |
2011-10-26 |
주식회사 엘지화학 |
위상차 필름, 이를 포함하는 편광판 및 액정 표시 장치
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
JP5057056B2
(ja)
|
2007-08-03 |
2012-10-24 |
Jsr株式会社 |
液晶配向剤、液晶配向膜の製造方法、ポリアミック酸およびポリイミドならびにジアミン化合物
|
WO2009047105A1
(en)
|
2007-10-10 |
2009-04-16 |
Basf Se |
Sulphonium salt initiators
|
JP2009108152A
(ja)
|
2007-10-29 |
2009-05-21 |
Sumitomo Chemical Co Ltd |
重合性化合物および光学フィルム
|
WO2009078992A1
(en)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Linear tricyclic compounds as p38 kinase inhibitors
|
JP2009149754A
(ja)
|
2007-12-20 |
2009-07-09 |
Sumitomo Chemical Co Ltd |
重合性化合物および該重合性化合物を重合してなる光学フィルム
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
UY31770A1
(es)
|
2008-04-18 |
2009-09-30 |
|
Inhibidores de catepsina c
|
KR101892989B1
(ko)
|
2008-06-27 |
2018-08-30 |
셀젠 카르 엘엘씨 |
헤테로아릴 화합물 및 이의 용도
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
JP2010066630A
(ja)
|
2008-09-12 |
2010-03-25 |
Sumitomo Chemical Co Ltd |
光学フィルムの製造方法及び光学フィルム
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
EP2367824B1
(en)
|
2008-12-23 |
2016-03-23 |
AbbVie Inc. |
Anti-viral derivatives of pyrimidine
|
JP5899607B2
(ja)
|
2009-03-16 |
2016-04-06 |
住友化学株式会社 |
化合物、光学フィルム及び光学フィルムの製造方法
|
TWI482769B
(zh)
|
2009-03-16 |
2015-05-01 |
Sumitomo Chemical Co |
化合物、光學膜片及光學膜片之製造方法
|
JP2011006360A
(ja)
|
2009-06-26 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルム及び光学フィルムの製造方法
|
JP2011042606A
(ja)
|
2009-08-20 |
2011-03-03 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルム及び光学フィルムの製造方法
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
EP2470183B1
(en)
|
2009-08-26 |
2015-09-16 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
WO2011031934A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2011053825A2
(en)
|
2009-10-30 |
2011-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment or prevention of mitochondrial diseases
|
ES2550667T3
(es)
|
2010-02-18 |
2015-11-11 |
Vtv Therapeutics Llc |
Derivados de fenilheteroarilo y métodos de uso de los mismos
|
CN110269856A
(zh)
|
2010-03-30 |
2019-09-24 |
维颂公司 |
多取代芳族化合物作为凝血酶的抑制剂
|
CA2798325A1
(en)
|
2010-05-13 |
2011-11-17 |
Amgen Inc. |
Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
|
GB201010359D0
(en)
|
2010-06-21 |
2010-08-04 |
Univ Nottingham |
Compounds for treating proliferative disorders
|
SG186850A1
(en)
|
2010-07-29 |
2013-02-28 |
Rigel Pharmaceuticals Inc |
Ampk-activating heterocyclic compounds and methods for using the same
|
WO2012078855A1
(en)
|
2010-12-08 |
2012-06-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Substituted pyrazolopyrimidines as glucocerebrosidase activators
|
JP5728921B2
(ja)
|
2010-12-10 |
2015-06-03 |
コニカミノルタ株式会社 |
光学フィルム、及びそれを用いた偏光板、液晶表示装置
|
EP2651927A4
(en)
|
2010-12-15 |
2014-06-04 |
Abbvie Inc |
ANTIVIRAL CONNECTIONS
|
WO2012083048A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
CA2832473A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use
|
RU2013156864A
(ru)
|
2011-05-23 |
2015-06-27 |
Санофи |
Способ получения дейтерированных соединений, содержащих n-алкильные группы
|
PT2713722T
(pt)
|
2011-05-31 |
2017-06-27 |
Receptos Llc |
Novos estabilizadores e moduladores do receptor glp-1
|
CN103929961A
(zh)
|
2011-06-20 |
2014-07-16 |
美国阿尔茨海默病研究所公司 |
化合物及其治疗应用
|
WO2012177997A1
(en)
|
2011-06-22 |
2012-12-27 |
The General Hospital Corporation |
Treatment of proteinopathies
|
CN103958506B
(zh)
|
2011-09-27 |
2017-02-22 |
诺华股份有限公司 |
用作突变idh抑制剂的3‑嘧啶‑4‑基‑噁唑烷‑2‑酮化合物
|
WO2013052845A1
(en)
|
2011-10-05 |
2013-04-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
US9012443B2
(en)
|
2011-12-07 |
2015-04-21 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
WO2013106678A1
(en)
|
2012-01-12 |
2013-07-18 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
TW201348231A
(zh)
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
EP2671885A1
(en)
|
2012-06-05 |
2013-12-11 |
Ares Trading S.A. |
Imidazo-oxadiazole and Imidazo-thiadiazole derivatives
|
FR2992317B1
(fr)
|
2012-06-22 |
2016-05-13 |
Diverchim |
Procede de preparation de peptides chiraux
|
CN104411800B
(zh)
|
2012-06-26 |
2016-11-23 |
默克专利股份有限公司 |
制备双折射聚合物膜的方法
|
CA2883480A1
(en)
|
2012-09-17 |
2014-03-20 |
F. Hoffmann-La Roche Ag |
Usp30 inhibitors and methods of use
|
EA201500393A1
(ru)
|
2012-11-02 |
2016-05-31 |
Пфайзер Инк. |
Ингибиторы тирозинкиназы брутона
|
CA2888324A1
(en)
|
2012-11-07 |
2014-05-15 |
Alexander Flohr |
Triazolo compounds
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
CA2905830C
(en)
|
2013-03-12 |
2022-01-18 |
Curegenix Inc. |
Quinazoline and naphthyridine derivatives useful in the treatment of cancer
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
EP2968321A4
(en)
|
2013-03-14 |
2016-11-09 |
Curegenix Inc |
COMPOUNDS FOR THE TREATMENT OF FIBROSIS DISEASES
|
RU2015141592A
(ru)
|
2013-03-15 |
2017-04-21 |
Ф. Хоффманн-Ля Рош Аг |
АРИЛ-СУЛЬФАМИДЫ И СУЛЬФАМАТЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ RORc
|
US9393244B2
(en)
|
2013-03-15 |
2016-07-19 |
Georgetown University |
Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
US20160145304A1
(en)
|
2013-07-12 |
2016-05-26 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Cystobactamides
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
WO2015010297A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
KR101715090B1
(ko)
|
2013-08-28 |
2017-03-13 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
JP6615752B2
(ja)
|
2013-09-30 |
2019-12-04 |
グアンジョウ・イノケア・ファーマ・テク・カンパニー・リミテッド |
Btkの置換ニコチンイミド阻害剤およびそれらの調製、ならびにがん、炎症および自己免疫疾患の治療における使用
|
WO2015061247A2
(en)
|
2013-10-21 |
2015-04-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
KR102243116B1
(ko)
|
2013-10-21 |
2021-04-22 |
메르크 파텐트 게엠베하 |
복굴절성 중합체 필름의 제조 방법
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
WO2015095104A1
(en)
|
2013-12-18 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as bace inhibitors, compositions, and their use
|
WO2015106292A1
(en)
|
2014-01-13 |
2015-07-16 |
Coferon, Inc. |
Bcr-abl tyrosine-kinase ligands capable of dimerizing in an aqueous solution, and methods of using same
|
US9663504B2
(en)
|
2014-02-25 |
2017-05-30 |
Board Of Regents, The University Of Texas System |
Salts of heterocyclic modulators of HIF activity for treatment of disease
|
RS61810B1
(sr)
|
2014-05-13 |
2021-06-30 |
Hoffmann La Roche |
Deuterisana heterociklična jedinjenja i njihova upotreba kao sredstva za snimanje
|
EP3147283B1
(en)
|
2014-05-22 |
2022-08-17 |
North China Pharmaceutical Company., Ltd. |
Hydrazine compound as blood coagulation factor xa inhibitor
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
GB201410653D0
(en)
|
2014-06-14 |
2014-07-30 |
Mission Therapeutics Ltd |
Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner
|
CN106065009B
(zh)
|
2014-06-28 |
2019-03-01 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的化合物及其在药物中的应用
|
EP3166939B1
(en)
|
2014-07-07 |
2019-06-05 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
JP2017520612A
(ja)
|
2014-07-16 |
2017-07-27 |
ノボジェン リミティッド |
抗がん剤としての官能化され置換されたインドール
|
WO2016019237A2
(en)
|
2014-07-31 |
2016-02-04 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
US9290457B2
(en)
|
2014-07-31 |
2016-03-22 |
Boehringer Ingelheim International Gmbh |
Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
|
EP3189551B1
(de)
|
2014-09-05 |
2021-01-27 |
Merck Patent GmbH |
Formulierungen und verfahren zur herstellung einer organischen elektrolumineszenzvorrichtung
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
GB201416754D0
(en)
|
2014-09-23 |
2014-11-05 |
Mission Therapeutics Ltd |
Novel compounds
|
US9997717B2
(en)
|
2014-12-12 |
2018-06-12 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescence device and electronic device
|
CN104557862B
(zh)
|
2014-12-15 |
2017-05-17 |
苏州云轩医药科技有限公司 |
具有Wnt信号通路抑制活性的杂环化合物
|
DK3240785T3
(da)
|
2014-12-29 |
2021-09-27 |
Us Health |
Småmolekylede hæmmere af laktasedehydrogenase og fremgangsmåder til brug deraf
|
MD3277677T2
(ro)
*
|
2015-03-30 |
2021-07-31 |
Mission Therapeutics Ltd |
Compuși de 1-ciano-pirolidină utilizați ca inhibitori de USP30
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
WO2017002120A1
(en)
|
2015-07-02 |
2017-01-05 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of senescent cells and uses thereof
|
WO2017010399A1
(ja)
|
2015-07-10 |
2017-01-19 |
塩野義製薬株式会社 |
RORγt阻害作用を有する化合物およびそれらを含有する医薬組成物
|
EP3322702B1
(en)
|
2015-07-14 |
2019-11-20 |
Mission Therapeutics Limited |
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
|
WO2017019822A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Pellet composition containing repair cells
|
WO2017019830A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017019817A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017040982A1
(en)
|
2015-09-02 |
2017-03-09 |
The Regents Of The University Of California |
Her3 ligands and uses thereof
|
WO2017040194A1
(en)
|
2015-09-04 |
2017-03-09 |
Dow Agrosciences Llc |
Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
|
US20180305334A1
(en)
|
2015-10-14 |
2018-10-25 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
GB201521109D0
(en)
|
2015-11-30 |
2016-01-13 |
Mission Therapeutics Ltd |
Novel compounds
|
MA43417A
(fr)
|
2015-12-09 |
2018-10-17 |
Res Triangle Inst |
Agonistes améliorés du récepteur de l'apéline (apj) et leurs utilisations
|
GB201522267D0
(en)
*
|
2015-12-17 |
2016-02-03 |
Mission Therapeutics Ltd |
Novel compounds
|
GB201522768D0
(en)
|
2015-12-23 |
2016-02-03 |
Mission Therapeutics Ltd |
Novel compounds
|
CN106986859B
(zh)
|
2016-01-20 |
2020-02-11 |
广东东阳光药业有限公司 |
吲哚衍生物及其用途
|
GB201602854D0
(en)
|
2016-02-18 |
2016-04-06 |
Mission Therapeutics Ltd |
Novel compounds
|
GB201603779D0
(en)
|
2016-03-04 |
2016-04-20 |
Mission Therapeutics Ltd |
Novel compounds
|
ES2947636T3
(es)
|
2016-03-16 |
2023-08-14 |
Kura Oncology Inc |
Derivados de tieno[2,3-d]pirimidina sustituida como inhibidores de menina-MLL y métodos de uso
|
GB201604647D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
CN107226805A
(zh)
|
2016-03-24 |
2017-10-03 |
北京天诚医药科技有限公司 |
芳香族酰胺类衍生物、其制备方法及其在医药上的应用
|
EP3433246B1
(en)
*
|
2016-03-24 |
2022-05-04 |
Mission Therapeutics Limited |
1-cyano-pyrrolidine derivatives as dbu inhibitors
|
AR108906A1
(es)
|
2016-06-29 |
2018-10-10 |
Bristol Myers Squibb Co |
Heterociclos de biarilmetilo
|
CN107619384B
(zh)
|
2016-07-13 |
2020-07-28 |
江苏恒瑞医药股份有限公司 |
苯并杂环衍生物、其制备方法及其在医药上的应用
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
WO2018024188A1
(zh)
|
2016-08-02 |
2018-02-08 |
上海迪诺医药科技有限公司 |
多环化合物、其制备方法、药物组合物及应用
|
US11124628B2
(en)
|
2016-08-30 |
2021-09-21 |
Dow Global Technologies Llc |
Method of attenuating concerntration of acrolein
|
ES2850349T3
(es)
|
2016-09-27 |
2021-08-27 |
Mission Therapeutics Ltd |
Derivados de cianopirrolidina con actividad como inhibidores de USP30
|
GB201616511D0
(en)
|
2016-09-29 |
2016-11-16 |
Mission Therapeutics Limited |
Novel compounds
|
GB201616627D0
(en)
*
|
2016-09-30 |
2016-11-16 |
Mission Therapeutics Limited |
Novel compounds
|
TWI771327B
(zh)
|
2016-10-05 |
2022-07-21 |
英商使命醫療公司 |
新穎化合物
|
WO2018106820A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
EP3571198B1
(en)
|
2017-01-20 |
2023-02-01 |
LEO Pharma A/S |
Bicyclic amines as jak kinase inhibitors
|
US20190367537A1
(en)
|
2017-02-08 |
2019-12-05 |
Helmholtz-Zentrum Dresden - Rossendorf E.V. |
In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics)
|
US10744213B2
(en)
|
2017-02-14 |
2020-08-18 |
Colossus Biopharma Consultants Company, Limited |
Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents
|
WO2018160891A1
(en)
|
2017-03-01 |
2018-09-07 |
Achillion Pharmaceutical, Inc. |
Pharmaceutical compounds for treatment of medical disorders
|
CN111094250B
(zh)
|
2017-03-03 |
2022-11-04 |
江苏豪森药业集团有限公司 |
凋亡信号调节激酶抑制剂及其制备方法和应用
|
US10968172B2
(en)
|
2017-05-15 |
2021-04-06 |
Mitobridge, Inc. |
USP30 inhibitors
|
GB201708652D0
(en)
|
2017-05-31 |
2017-07-12 |
Mission Therapeutics Ltd |
Novel compounds and uses
|
EP3642196B1
(en)
|
2017-06-20 |
2022-08-17 |
Mission Therapeutics Limited |
Substituted cyanopyrrolidines with activity as dub inhibitors
|
AU2018346597B2
(en)
|
2017-10-06 |
2023-07-13 |
Forma Therapeutics, Inc. |
Inhibiting Ubiquitin Specific Peptidase 30
|
GB2571731A
(en)
|
2018-03-06 |
2019-09-11 |
Mission Therapeutics Ltd |
Novel compounds and uses
|
SG11202011299PA
(en)
|
2018-05-17 |
2020-12-30 |
Forma Therapeutics Inc |
Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
|
WO2020036940A1
(en)
|
2018-08-14 |
2020-02-20 |
Amgen Inc. |
N-cyano-7-azanorbornane derivatives and uses thereof
|
BR112021003620A2
(pt)
|
2018-10-05 |
2021-05-18 |
Forma Therapeutics, Inc. |
pirrolinas fundidas que atuam como inibidoras da protease específica para a ubiquitina 30 (usp30)
|
GB201905371D0
(en)
|
2019-04-16 |
2019-05-29 |
Mission Therapeutics Ltd |
Novel compounds
|
GB201905375D0
(en)
|
2019-04-16 |
2019-05-29 |
Mission Therapeutics Ltd |
Novel compounds
|
GB201912674D0
(en)
|
2019-09-04 |
2019-10-16 |
Mission Therapeutics Ltd |
Novel compounds
|
CN115038688A
(zh)
|
2019-09-11 |
2022-09-09 |
文森雷生物科学股份有限公司 |
Usp30抑制剂及其用途
|